Statistics in Medicine, published by Wiley, is a prestigious journal dedicated to the advancement of statistical methods and their application in biomedical research. Established in 1982, this journal has become a cornerstone in the fields of Epidemiology and Statistics and Probability, demonstrating its importance by consistently achieving a Q1 ranking in the 2023 category quartiles. With an impressive ISSN of 0277-6715 and an E-ISSN of 1097-0258, it serves as a vital platform for disseminating high-quality research that enhances evidence-based medicine. Although the journal does not currently offer open access, it remains highly regarded, holding a Scopus rank of #66 in Mathematics and #80 in Medicine, indicating its significant impact on the academic community. By publishing cutting-edge research, Statistics in Medicine aims to bridge the gap between statistical theory and practical application in health domains, fostering a rigorous dialogue among researchers, clinicians, and statisticians alike.

Therapeutic Innovation & Regulatory Science, published by Springer Heidelberg, is an esteemed journal that focuses on the intersection of therapeutic innovations and the regulatory frameworks that govern them. Established in 1970 and continuing its legacy of excellence through converged years, this journal plays a crucial role in supplying cutting-edge research, reviews, and discussions that advance understanding in the fields of pharmacology and healthcare regulation. With an impact factor reflective of its rigorous peer-review standards, this journal holds a prestigious Q1 ranking in Pharmacology, Toxicology, and Pharmaceutics (Miscellaneous) for 2023, reflecting its influence and the high quality of its published material. The journal's wide scope also embraces public health and environmental studies, making it an essential resource for researchers and professionals navigating these critical areas. Open access options enhance its visibility and accessibility, ensuring that the latest discoveries and regulatory insights are readily available to a global audience. For those at the forefront of medicinal science and regulatory affairs, Therapeutic Innovation & Regulatory Science is your avenue to understanding pivotal innovations that shape contemporary therapeutic practices.

Contemporary Clinical Trials Communications, published by ELSEVIER INC, serves as a pivotal resource in the evolving fields of medicine and pharmacology, especially with its commitment to open access since 2015. With the E-ISSN 2451-8654, this journal is dedicated to disseminating high-quality research that examines contemporary clinical trial methodologies and their applications in improving healthcare outcomes. Situated in the United States, its impressive ranking, with a Q2 status in both Medicine (miscellaneous) and Pharmacology for 2023, highlights its significance and impact within the scientific community. Ranking #199 out of 636 in General Medicine and #217 out of 313 in Pharmacology on the Scopus scale, the journal aims to foster innovative discussions and developments among researchers, professionals, and students, making it an essential tool for those seeking to stay at the forefront of clinical research and trials.

Clinical Pharmacology in Drug Development, published by WILEY, is a distinguished journal dedicated to advancing the field of pharmaceutical science and drug development. With a strong commitment to disseminating cutting-edge research, this journal serves as a crucial platform for professionals, researchers, and students aiming to enhance their understanding of pharmacological principles and innovations in medical therapeutics. Since its inception in 2012, the journal has consistently maintained a noteworthy presence in the academic community, currently achieving a Q2 ranking in both Pharmaceutical Science and Medical Pharmacology categories as of 2023. Although the journal operates under a subscription model, it is highly regarded for its rigorous peer-reviewed publications, offering insights into drug efficacy, safety, and regulatory challenges. Positioned at the intersection of clinical practices and pharmaceutical advancements, Clinical Pharmacology in Drug Development plays an essential role in bridging the gap between scientific research and real-world application, ensuring that the latest therapeutic strategies are optimized for patient care.

JIRSS - Journal of the Iranian Statistical Society is a prominent academic journal dedicated to the field of statistics and probability, published by the esteemed Iranian Statistical Society. With its ISSN number 1726-4057 and E-ISSN 2538-189X, this journal serves as a vital platform for disseminating cutting-edge research and advancements in statistical methodology and its applications. Established in 2011, JIRSS has consistently contributed to the academic community, achieving a 2023 Scopus rank of #180 out of 278 in its category, placing it within the 35th percentile in the dynamic domain of Mathematics: Statistics and Probability. As an Open Access publication, it enhances accessibility for researchers, professionals, and students, facilitating a wider engagement with innovative statistical techniques and theories. The journal aims to foster collaboration and knowledge exchange among statisticians, ultimately enriching the field and its impact on various scientific disciplines.

BMC Medical Research Methodology is a prestigious open-access journal published by BMC, dedicated to advancing the field of medical research methodologies. Launched in 2001, the journal has established itself as a vital resource for researchers, reflecting its high-quality contributions with a strong Q1 ranking in both Epidemiology and Health Informatics as of 2023. As a scholarly platform, it offers broad access globally, ensuring that the latest developments in research methodology are readily available to professionals, scholars, and students alike. With its commitment to enhancing the rigor and transparency of medical research, BMC Medical Research Methodology plays a critical role in shaping the future of evidence-based practices, making it an essential read for anyone involved in medical research. The journal is based in the United Kingdom at CAMPUS, 4 Crinan St, London N1 9XW, England, and provides comprehensive access options to facilitate the dissemination of knowledge and foster collaboration across the global research community.

Statistics in Biopharmaceutical Research, published by Taylor & Francis Inc, is a premier journal that occupies a crucial space in the realms of Pharmaceutical Science and Statistics and Probability. With a robust impact factor affirmed by its Q1 rankings in both categories, the journal stands as a beacon for innovative statistical methodologies and their applications in biopharmaceutical research. Researchers and professionals will find a rich repository of high-quality articles that address contemporary challenges in drug development, clinical trials, and regulatory frameworks. Since its inception in 2011, the journal has continued to foster interdisciplinary collaboration, making significant strides towards enhancing statistical practice in biomedicine. With a commitment to academic rigor and practical relevance, Statistics in Biopharmaceutical Research is an essential resource for anyone looking to advance their understanding and application of statistical techniques in the pharmaceutical industry.

SCANDINAVIAN JOURNAL OF STATISTICS is a premier publication in the field of statistics, published by Wiley. With an impressive impact factor that reflects its influence, this journal is recognized for its rigorous peer-reviewed research articles that contribute to the advancement of statistical methods and their applications. As a leading resource, the journal spans a wide range of topics within Statistics and Probability, maintaining a strong scholarly presence with a Q1 rank in Statistics and Probability and a Q2 rank in Statistics, Probability and Uncertainty as per the 2023 category quartiles. The journal has been diligently publishing high-quality research since 1996, and now encompasses studies up to 2024, reinforcing its commitment to providing valuable insights for researchers, professionals, and students alike. While the journal does not offer open access, it remains an essential repository of knowledge in statistical sciences, fostering collaboration and innovation within the global academic community.

Welcome to the Electronic Journal of Applied Statistical Analysis, a pivotal platform for researchers and practitioners in the domains of Statistics and Probability, as well as Modeling and Simulation. Published by Università del Salento in Italy, this journal has been dedicated to disseminating valuable insights and advancements in applied statistical methodology since its inception in 2008. With its ISSN of 2070-5948, the journal operates within an esteemed academic framework, contributing significantly to the field despite its current Q4 ranking in both Statistics and Probability and Modeling and Simulation categories as of 2023. As we continue to explore complex statistical models and simulation techniques, the journal encourages submissions that advance theoretical and practical understandings, inviting the global academic community to engage with transformative research endeavors. For those looking to stay informed and ahead in the dynamic world of applied statistics, the Electronic Journal of Applied Statistical Analysis is an essential resource.

Statistics in Biosciences is a distinguished journal published by Springer, focusing on the innovative interplay between statistical methodologies and biosciences. Established in 2009, this journal aims to provide a platform for the dissemination of cutting-edge research in statistical applications within biochemistry, genetics, and molecular biology. With an impressive impact factor and a distinguished ranking in multiple categories, including Q2 in Biochemistry, Genetics and Molecular Biology (miscellaneous) and Q3 in Statistics and Probability, it serves as a crucial resource for researchers, professionals, and students seeking to deepen their understanding of statistical applications in biological contexts. The journal is accessible through traditional subscription models, ensuring that high-quality research remains available to a wide audience. Featuring contributions that advance statistical theory and application in the biosciences, Statistics in Biosciences is committed to fostering collaboration and innovation in a rapidly evolving scientific landscape.